BRIEF published on 02/20/2026 at 20:20, 27 days 10 hours ago IntegraGen: Annual Review and Continued Strategic Refocusing Revenue Treasury Certifications Profitability Biopharma
BRIEF published on 10/29/2025 at 17:50, 4 months 21 days ago IntegraGen: Lower Results, Reduced Expenses in the First Half of 2025 Financial Results Treasury Cost Reduction Genomics CLIA/CAP Certification
BRIEF published on 07/02/2025 at 07:35, 8 months 17 days ago IntegraGen Reports Decline in Sales and Cash Reserves Sales Decline Operational Costs IntegraGen Financing Needs Genomic Analyses
PRESS RELEASE published on 07/02/2025 at 07:30, 8 months 17 days ago Inside Information / Other news releases IntegraGen reports sales of €2.5 million in the first half of 2025, a 31% decrease in sequencing activities at Évry and challenges with cash position leading to exploration of strategic options Sales Cash Position Strategic Options IntegraGen Decrease
BRIEF published on 01/15/2025 at 18:49, 1 year 2 months ago IntegraGen revenue down for 2024 Treasury Growth Turnover Genomics SeqOIA
PRESS RELEASE published on 01/15/2025 at 18:44, 1 year 2 months ago Inside Information / Information on annual revenues IntegraGen, an OncoDNA Group company, reports 27% revenue drop in 2024 due to SeqOIA services cessation. Cash position at €1.9m. Growth seen outside SeqOIA Cash Position Growth Prospects Revenue Drop SeqOIA IntegraGen
BRIEF published on 07/18/2024 at 18:49, 1 year 8 months ago IntegraGen: Revenue up despite loss of SeqOIA Growth Turnover CLIA Certification SeqOIA Genomic
Published on 03/20/2026 at 03:10, 3 hours 18 minutes ago Future Fuels Announces Filing of Amended and Restated Life Offering Document
Published on 03/20/2026 at 00:20, 6 hours 8 minutes ago Prospect Ridge To Host Investor Webinar With Presentation And Audience Q&A
Published on 03/20/2026 at 00:20, 6 hours 8 minutes ago Reeflex Solutions Inc. Announces Revocation of Management Cease Trade Order
Published on 03/19/2026 at 21:16, 9 hours 12 minutes ago Unusual Machines, Inc. Announces Proposed Public Offering
Published on 03/19/2026 at 14:20, 16 hours 8 minutes ago CBMJ CEO Rips Legacy Liberal Media Over Iran Coverage on The Schaftlein Report
Published on 03/20/2026 at 03:05, 3 hours 23 minutes ago HEROAD Unleashes a New Era of Gaming: Professional-Grade Gear Meets Unbeatable Value
Published on 03/19/2026 at 23:48, 6 hours 40 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C daily buy back notice
Published on 03/19/2026 at 22:55, 7 hours 33 minutes ago Baristas behind millions of cups of coffee compete globally
Published on 03/19/2026 at 22:48, 7 hours 40 minutes ago EQS-Adhoc: Forecast for the 2026 financial year
Published on 03/19/2026 at 18:00, 12 hours 28 minutes ago Filing of the 2025 Universal Registration Document
Published on 03/19/2026 at 08:45, 21 hours 43 minutes ago Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 23 hours 28 minutes ago bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 23 hours 28 minutes ago 2025 Annual results and new strategic signature
